282 related articles for article (PubMed ID: 33017186)
1. Class IIa HDAC inhibitor TMP195 alleviates lipopolysaccharide-induced acute kidney injury.
Zhang W; Guan Y; Bayliss G; Zhuang S
Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1015-F1026. PubMed ID: 33017186
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HDAC6 protects against rhabdomyolysis-induced acute kidney injury.
Shi Y; Xu L; Tang J; Fang L; Ma S; Ma X; Nie J; Pi X; Qiu A; Zhuang S; Liu N
Am J Physiol Renal Physiol; 2017 Mar; 312(3):F502-F515. PubMed ID: 28052874
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of class IIa histone deacetylases alleviates renal fibrosis.
Xiong C; Guan Y; Zhou X; Liu L; Zhuang MA; Zhang W; Zhang Y; Masucci MV; Bayliss G; Zhao TC; Zhuang S
FASEB J; 2019 Jul; 33(7):8249-8262. PubMed ID: 30951378
[TBL] [Abstract][Full Text] [Related]
4. PROPHYLACTIC n CMT-3 ATTENUATES SEPSIS-INDUCED ACUTE KIDNEY INJURY IN ASSOCIATION WITH NLRP3 INFLAMMASOME ACTIVATION AND APOPTOSIS.
Ma J; Wang X; Gu R; Guo D; Shi C; Kollisch-Singule M; Suo L; Luo J; Meng Q; Cooney RN
Shock; 2023 Jun; 59(6):922-929. PubMed ID: 36939682
[TBL] [Abstract][Full Text] [Related]
5. Class IIa histone deacetylase inhibition ameliorates acute kidney injury by suppressing renal tubular cell apoptosis and enhancing autophagy and proliferation.
Li J; Yu C; Shen F; Cui B; Liu N; Zhuang S
Front Pharmacol; 2022; 13():946192. PubMed ID: 35935816
[TBL] [Abstract][Full Text] [Related]
6. α2-Adrenoceptor agonist dexmedetomidine protects septic acute kidney injury through increasing BMP-7 and inhibiting HDAC2 and HDAC5.
Hsing CH; Lin CF; So E; Sun DP; Chen TC; Li CF; Yeh CH
Am J Physiol Renal Physiol; 2012 Nov; 303(10):F1443-53. PubMed ID: 22933299
[TBL] [Abstract][Full Text] [Related]
7. Epigenomic mechanisms of alcohol-induced impaired differentiation of skeletal muscle stem cells; role of Class IIA histone deacetylases.
Adler K; Molina PE; Simon L
Physiol Genomics; 2019 Sep; 51(9):471-479. PubMed ID: 31398085
[TBL] [Abstract][Full Text] [Related]
8. Chidamide, a histone deacetylase inhibitor, functions as a tumor inhibitor by modulating the ratio of Bax/Bcl-2 and P21 in pancreatic cancer.
Zhao B; He T
Oncol Rep; 2015 Jan; 33(1):304-10. PubMed ID: 25384499
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Class IIa HDACs improves endothelial barrier function in endotoxin-induced acute lung injury.
Kovacs-Kasa A; Kovacs L; Cherian-Shaw M; Patel V; Meadows ML; Fulton DJ; Su Y; Verin AD
J Cell Physiol; 2021 Apr; 236(4):2893-2905. PubMed ID: 32959895
[TBL] [Abstract][Full Text] [Related]
10. The Selective Class IIa Histone Deacetylase Inhibitor TMP195 Resensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs.
Wu CP; Lusvarghi S; Wang JC; Hsiao SH; Huang YH; Hung TH; Ambudkar SV
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905792
[TBL] [Abstract][Full Text] [Related]
11. TMP195 Exerts Antitumor Effects on Colorectal Cancer by Promoting M1 Macrophages Polarization.
Han Y; Sun J; Yang Y; Liu Y; Lou J; Pan H; Yao J; Han W
Int J Biol Sci; 2022; 18(15):5653-5666. PubMed ID: 36263186
[TBL] [Abstract][Full Text] [Related]
12. The Nephroprotective Effect of MS-275 on Lipopolysaccharide (LPS)-Induced Acute Kidney Injury by Inhibiting Reactive Oxygen Species (ROS)-Oxidative Stress and Endoplasmic Reticulum Stress.
Zhang H; Zhang W; Jiao F; Li X; Zhang H; Wang L; Gong Z
Med Sci Monit; 2018 Apr; 24():2620-2630. PubMed ID: 29704392
[TBL] [Abstract][Full Text] [Related]
13. HDAC5 inhibition reduces angiotensin II-induced vascular contraction, hypertrophy, and oxidative stress in a mouse model.
Bai L; Kee HJ; Choi SY; Seok YM; Kim GR; Kee SJ; Kook H; Jeong MH
Biomed Pharmacother; 2021 Feb; 134():111162. PubMed ID: 33360932
[TBL] [Abstract][Full Text] [Related]
14. Dynamic changes in histone deacetylases following kidney ischemia-reperfusion injury are critical for promoting proximal tubule proliferation.
Hyndman KA; Kasztan M; Mendoza LD; Monteiro-Pai S
Am J Physiol Renal Physiol; 2019 May; 316(5):F875-F888. PubMed ID: 30810062
[TBL] [Abstract][Full Text] [Related]
15. Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling.
Liu N; He S; Ma L; Ponnusamy M; Tang J; Tolbert E; Bayliss G; Zhao TC; Yan H; Zhuang S
PLoS One; 2013; 8(1):e54001. PubMed ID: 23342059
[TBL] [Abstract][Full Text] [Related]
16. Flavonoid fisetin alleviates kidney inflammation and apoptosis via inhibiting Src-mediated NF-κB p65 and MAPK signaling pathways in septic AKI mice.
Ren Q; Guo F; Tao S; Huang R; Ma L; Fu P
Biomed Pharmacother; 2020 Feb; 122():109772. PubMed ID: 31918290
[TBL] [Abstract][Full Text] [Related]
17. Roflumilast, a Phosphodiesterases-4 (PDE4) Inhibitor, Alleviates Sepsis‑induced Acute Kidney Injury.
Xu X; Liao L; Hu B; Jiang H; Tan M
Med Sci Monit; 2020 May; 26():e921319. PubMed ID: 32449901
[TBL] [Abstract][Full Text] [Related]
18. Novel histone deacetylase 8-selective inhibitor 1,3,4-oxadiazole-alanine hybrid induces apoptosis in breast cancer cells.
Pidugu VR; Yarla NS; Bishayee A; Kalle AM; Satya AK
Apoptosis; 2017 Nov; 22(11):1394-1403. PubMed ID: 28840369
[TBL] [Abstract][Full Text] [Related]
19. Histone Deacetylase 9 Activates IKK to Regulate Atherosclerotic Plaque Vulnerability.
Asare Y; Campbell-James TA; Bokov Y; Yu LL; Prestel M; El Bounkari O; Roth S; Megens RTA; Straub T; Thomas K; Yan G; Schneider M; Ziesch N; Tiedt S; Silvestre-Roig C; Braster Q; Huang Y; Schneider M; Malik R; Haffner C; Liesz A; Soehnlein O; Bernhagen J; Dichgans M
Circ Res; 2020 Aug; 127(6):811-823. PubMed ID: 32546048
[TBL] [Abstract][Full Text] [Related]
20. Effects of novel HDAC inhibitors on urothelial carcinoma cells.
Kaletsch A; Pinkerneil M; Hoffmann MJ; Jaguva Vasudevan AA; Wang C; Hansen FK; Wiek C; Hanenberg H; Gertzen C; Gohlke H; Kassack MU; Kurz T; Schulz WA; Niegisch G
Clin Epigenetics; 2018 Jul; 10(1):100. PubMed ID: 30064501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]